Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Immunity|October 9, 2024
TIL the end: Tracking T cell clonotype dynamics during adoptive cell therapyAnthony C Buzzai, Thomas TütingFrontiers in Immunology|July 13, 2026
Oncolytic virotherapy counteracts the selection of IFN-unresponsive cancer cells post-immunotherapy but is limited by the emergence of dedifferentiated cancer cellsSusan Gellert, Bastian Kruse, Johannes Peters, et al.Frontiers in Immunology|February 1, 2019
CD8<sup>+</sup>XCR1<sup>neg</sup> Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic ReceptorsBen Wylie, James Read, Anthony C Buzzai, et al.Frontiers in Immunology|April 21, 2020
Diverse Anti-Tumor Immune Potential Driven by Individual IFNα SubtypesAnthony C Buzzai, Teagan Wagner, Katherine M Audsley, et al.Frontiers in Immunology|September 23, 2021
IFNβ Is a Potent Adjuvant for Cancer Vaccination StrategiesKatherine M Audsley, Teagan Wagner, Clara Ta, et al.Science Advances|May 14, 2025
Interleukin-4 modulates type I interferon to augment antitumor immunityHannah V Newnes, Jesse D Armitage, Anthony C Buzzai, et al.Nature|June 14, 2023
CD4<sup>+</sup> T cell-induced inflammatory cell death controls immune-evasive tumoursBastian Kruse, Anthony C Buzzai, Naveen Shridhar, et al.Pageof 1